| |
|
|
|
Cellect Biotechnology Ltd.  
|
|
5.8315 0.051 (0.01%) |
09-21 10:48 |
|
Open: |
5.87 |
Pre close: |
5.78 |
Target:
|
8.15 
|
|
High: |
6.01 |
Low: |
5.72 |
Resistance:
|
6.98
8.88
|
|
Volume: |
67,311 |
Market Cap: |
23M |
Support:
|
3.91
3.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.16
 |
MACD |
MACD(12,26):
|
0.48 |
|
MA(20): |
5.61 |
Signal(12,26,9): |
0.52 |
|
MA(100): |
3.94 |
Stochastic Oscillator |
%K(14,3):
|
37.05 |
|
MA(250): |
3.17 |
%D(3): |
43.36 |
|
Average Volume(K) |
3-Month: |
15837694
|
52-Week |
High:
|
8.88 |
|
10-Days: |
68605 |
Low: |
1.65 |
|
RSI |
RSI(14):
|
54.58 |
Change(%): |
175.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.850 |
Return on Equity (ttm) |
-121.3 |
Shares Out. (M) |
3.91 |
|
EPS Est. Current Year |
-1.560 |
Return on Assets (ttm) |
-42.8 |
Shares Float (M) |
3.57 |
|
EPS Est. Next Year |
-1.350 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.65 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
15.60 |
|
Forward EPS |
-0.206 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
166 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.41 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
